Our leadership team has extensive experience in developing, obtaining regulatory approvals for and successfully commercializing a variety of oncology products. In total, they have decades of combined experience spanning a range of cancers and other diseases.

Martin Huber, M.D.

Senior Vice President, Chief Medical Officer

Martin Huber, M.D. has served as Senior Vice President, Chief Medical Officer since September 2015. Dr. Huber has more than 20 years of leadership experience in the biopharmaceutical industry. He most recently served as Vice President, Oncology Clinical Research at Merck Research Laboratories. Prior to Merck, he served in roles of increasing responsibility at Schering-Plough, Hoffmann-La Roche and Rhone-Poulenc Rorer, where he led teams in the areas of oncology clinical development, drug safety and pharmacovigilance. He was previously an Assistant Professor of Oncology at the University of Texas M.D. Anderson Cancer Center. Dr. Huber received his medical degree from Baylor College of Medicine.